Invivyd (IVVD)
Invivyd on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as biological products, (no diagnostic substances).
37.0M
Short interest
settlement 2026-10-15
6.9
Days to cover
+3.4 days vs prior
62.4%
Short share of volume
2026-11-03
1,000
Fails to deliver
settlement 2026-10-13
Thu 5 Nov
Next earnings
estimated date
-$177K
Insider flow, 90 days
0 buys, 10 sells
As of 2026-11-03.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in IVVD is 37,046,611 shares, up 6,490,217 shares over the last month. Over the last 48 readings it ranged from 3,048,959 shares (15 August 2025) to 37,046,611 shares (15 October 2026). The latest reading sits at the top of that range. At the reported average volume of 5.3M shares a day that is 6.9 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/ivvd" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 37,046,611 | +9.4% | 5,347,695 | 6.93 |
| 2026-09-30 | 33,858,191 | +10.8% | 9,457,288 | 3.58 |
| 2026-09-15 | 30,556,394 | +2.6% | 3,967,514 | 7.70 |
| 2026-08-31 | 29,787,846 | -3.6% | 4,493,548 | 6.63 |
| 2026-08-14 | 30,916,751 | +11.2% | 2,750,200 | 11.24 |
| 2026-07-31 | 27,804,425 | -5.1% | 3,128,316 | 8.89 |
| 2026-07-15 | 29,311,996 | +6.8% | 3,426,249 | 8.56 |
| 2026-06-30 | 27,441,668 | -20.3% | 7,615,017 | 3.60 |
| 2026-06-15 | 34,434,138 | +11.3% | 5,745,004 | 5.99 |
| 2026-05-29 | 30,932,931 | -0.4% | 2,905,982 | 10.64 |
| 2026-05-15 | 31,069,631 | +6.2% | 3,278,318 | 9.48 |
| 2026-04-30 | 29,263,723 | +0.0% | 1,345,716 | 21.75 |
| 2026-04-15 | 29,260,030 | +10.5% | 5,230,733 | 5.59 |
| 2026-03-31 | 26,469,699 | +7.9% | 3,137,959 | 8.44 |
| 2026-03-13 | 24,528,343 | +8.2% | 2,381,744 | 10.30 |
| 2026-02-27 | 22,663,061 | -0.1% | 1,156,013 | 19.60 |
| 2026-02-13 | 22,693,507 | +1.6% | 3,385,179 | 6.70 |
| 2026-01-30 | 22,329,821 | +4.3% | 3,324,094 | 6.72 |
| 2026-01-15 | 21,413,384 | -39.9% | 3,214,101 | 6.66 |
| 2025-12-31 | 35,613,115 | +24.4% | 5,706,265 | 6.24 |
| 2025-12-15 | 28,634,579 | +1.4% | 4,176,602 | 6.86 |
| 2025-11-28 | 28,247,222 | +2.6% | 7,467,371 | 3.78 |
| 2025-11-14 | 27,536,464 | +14.1% | 15,353,011 | 1.79 |
| 2025-10-31 | 24,126,258 | +44.7% | 4,792,295 | 5.03 |
| 2025-10-15 | 16,671,545 | +157.0% | 8,425,804 | 1.98 |
| 2025-09-30 | 6,486,761 | -10.6% | 1,935,805 | 3.35 |
| 2025-09-15 | 7,258,514 | +37.6% | 4,981,796 | 1.46 |
| 2025-08-29 | 5,273,423 | +73.0% | 26,549,615 | 1.00 |
| 2025-08-15 | 3,048,959 | -8.4% | 718,745 | 4.24 |
| 2025-07-31 | 3,328,231 | -25.5% | 749,490 | 4.44 |
| 2025-07-15 | 4,468,017 | -9.2% | 593,500 | 7.53 |
| 2025-06-30 | 4,919,267 | -20.9% | 1,866,797 | 2.64 |
| 2025-06-13 | 6,222,812 | -3.8% | 1,225,831 | 5.08 |
| 2025-05-30 | 6,466,876 | -18.3% | 2,448,859 | 2.64 |
| 2025-05-15 | 7,912,127 | +5.0% | 3,392,816 | 2.33 |
| 2025-04-30 | 7,535,271 | +7.4% | 1,340,077 | 5.62 |
| 2025-04-15 | 7,014,128 | -15.1% | 1,526,393 | 4.60 |
| 2025-03-31 | 8,263,220 | +24.1% | 2,188,721 | 3.78 |
| 2025-03-14 | 6,661,413 | -28.8% | 3,103,293 | 2.15 |
| 2025-02-28 | 9,359,675 | +10.0% | 8,369,222 | 1.12 |
| 2025-02-14 | 8,506,739 | +28.5% | 77,202,212 | 1.00 |
| 2025-01-31 | 6,619,576 | +5.2% | 909,945 | 7.27 |
| 2025-01-15 | 6,290,968 | +58.0% | 2,738,048 | 2.30 |
| 2024-12-31 | 3,980,782 | +8.6% | 1,148,493 | 3.47 |
| 2024-12-13 | 3,666,275 | -24.4% | 734,957 | 4.99 |
| 2024-11-29 | 4,851,234 | -28.0% | 927,595 | 5.23 |
| 2024-11-15 | 6,741,303 | -18.5% | 599,608 | 11.24 |
| 2024-10-31 | 8,272,000 | +15.8% | 304,517 | 27.16 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 3 November 2026, the short share of IVVD volume is 62.4%, up 18.7 points over the last five sessions. Over the last 30 readings it ranged from 43.3% (28 October 2026) to 71.2% (9 October 2026). The latest reading is in line with the 30-session average of 61.6%, on 2.5M shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-03 | 1.5M | 2.5M | 62.4% | 1,700 |
| 2026-11-02 | 1.5M | 2.6M | 56.8% | 246,023 |
| 2026-10-30 | 1.7M | 2.9M | 59.4% | 201,114 |
| 2026-10-29 | 867K | 1.8M | 46.9% | 1,101 |
| 2026-10-28 | 699K | 1.6M | 43.3% | 2,101 |
| 2026-10-27 | 1.1M | 2.5M | 43.7% | 852 |
| 2026-10-26 | 825K | 1.3M | 62.9% | 0 |
| 2026-10-23 | 1.2M | 1.8M | 70.2% | 2,300 |
| 2026-10-22 | 2.0M | 3.2M | 62.7% | 0 |
| 2026-10-21 | 3.1M | 4.4M | 70.8% | 8,300 |
| 2026-10-20 | 912K | 1.3M | 69.7% | 15,300 |
| 2026-10-19 | 2.1M | 3.3M | 65.1% | 0 |
| 2026-10-16 | 1.0M | 1.6M | 63.0% | 91 |
| 2026-10-15 | 1.1M | 2.1M | 53.5% | 0 |
| 2026-10-14 | 1.2M | 2.0M | 62.1% | 8,302 |
| 2026-10-13 | 1.4M | 2.0M | 67.2% | 21,583 |
| 2026-10-12 | 1.2M | 1.7M | 69.1% | 27,163 |
| 2026-10-09 | 1.0M | 1.4M | 71.2% | 11 |
| 2026-10-08 | 4.1M | 6.2M | 65.4% | 405,877 |
| 2026-10-07 | 4.3M | 6.7M | 64.1% | 36,751 |
| 2026-10-06 | 2.0M | 3.0M | 66.9% | 24,319 |
| 2026-10-05 | 2.2M | 3.2M | 69.9% | 33,063 |
| 2026-10-02 | 2.9M | 4.2M | 68.5% | 1,504 |
| 2026-10-01 | 1.8M | 2.9M | 61.6% | 20,972 |
| 2026-09-30 | 3.7M | 6.0M | 62.0% | 601,688 |
| 2026-09-29 | 4.8M | 8.5M | 55.8% | 499,768 |
| 2026-09-28 | 2.6M | 4.3M | 60.1% | 29,269 |
| 2026-09-25 | 1.4M | 2.2M | 63.9% | 6,744 |
| 2026-09-24 | 2.1M | 4.0M | 53.1% | 56,304 |
| 2026-09-23 | 2.9M | 5.3M | 55.6% | 486,480 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 13 October 2026, the fails-to-deliver balance in IVVD is 1,000 shares, down 116,372 shares over the last settlement date. Over the last 30 readings it ranged from 5 shares (24 July 2026) to 344,718 shares (6 August 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-13 | 1,000 | $0.67 | $670 |
| 2026-10-05 | 117,372 | $0.82 | $96K |
| 2026-09-29 | 919 | $0.95 | $873 |
| 2026-09-21 | 3,392 | $0.76 | $3K |
| 2026-09-18 | 49,834 | $0.75 | $37K |
| 2026-09-16 | 37 | $0.83 | $31 |
| 2026-09-01 | 600 | $0.95 | $570 |
| 2026-08-28 | 500 | $0.90 | $450 |
| 2026-08-11 | 1,855 | $0.67 | $1K |
| 2026-08-06 | 344,718 | $0.60 | $207K |
| 2026-07-24 | 5 | $0.61 | $3 |
| 2026-07-17 | 324 | $0.79 | $256 |
| 2026-07-10 | 296,863 | $0.80 | $237K |
| 2026-07-08 | 44,155 | $0.94 | $42K |
| 2026-07-07 | 1,231 | $0.83 | $1K |
| 2026-07-06 | 384 | $0.89 | $342 |
| 2026-07-01 | 527 | $0.87 | $458 |
| 2026-06-15 | 6,501 | $0.77 | $5K |
| 2026-06-11 | 705 | $0.90 | $635 |
| 2026-06-10 | 6,316 | $0.99 | $6K |
| 2026-06-04 | 29 | $1.10 | $32 |
| 2026-06-02 | 26,921 | $1.22 | $33K |
| 2026-05-27 | 12,483 | $1.10 | $14K |
| 2026-05-21 | 204 | $1.09 | $222 |
| 2026-05-15 | 33,292 | $1.16 | $39K |
| 2026-05-05 | 1,043 | $1.47 | $2K |
| 2026-05-01 | 28 | $1.40 | $39 |
| 2026-04-16 | 5,372 | $1.71 | $9K |
| 2026-04-14 | 30,406 | $1.72 | $52K |
| 2026-04-10 | 97,082 | $1.78 | $173K |
Insider trades
SEC Form 4, newest first. JSONInsiders at IVVD reported 10 open-market sells worth $177K in the last 90 days and no open-market buys. Latest filing: Allen Robert D. III (Chief Scientific Officer) on 2026-08-18.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-08-18 | Allen Robert D. III | Chief Scientific Officer | Sell | 17K | $0.84 | $14K | 179K |
| 2026-08-18 | Andersen Jill | Chief Legal Officer, Secretary | Sell | 31K | $0.84 | $26K | 284K |
| 2026-08-18 | Duke William E. | Chief Financial Officer | Sell | 18K | $0.84 | $16K | 169K |
| 2026-08-18 | Green Julie | Chief Human Resources Officer | Sell | 18K | $0.84 | $16K | 169K |
| 2026-08-18 | Lee Timothy Edward | Chief Commercial Officer | Sell | 18K | $0.84 | $16K | 179K |
| 2026-08-17 | Allen Robert D. III | Chief Scientific Officer | Sell | 21K | $0.72 | $15K | 196K |
| 2026-08-17 | Andersen Jill | Chief Legal Officer, Secretary | Sell | 37K | $0.72 | $27K | 314K |
| 2026-08-17 | Duke William E. | Chief Financial Officer | Sell | 22K | $0.72 | $16K | 187K |
| 2026-08-17 | Green Julie | Chief Human Resources Officer | Sell | 22K | $0.72 | $16K | 187K |
| 2026-08-17 | Lee Timothy Edward | Chief Commercial Officer | Sell | 22K | $0.72 | $16K | 197K |
| 2026-08-15 | Allen Robert D. III | Chief Scientific Officer | Exercise or conversion | 102K | price not stated in the filing | not stated | 216K |
| 2026-08-15 | Andersen Jill | Chief Legal Officer, Secretary | Exercise or conversion | 170K | price not stated in the filing | not stated | 352K |
| 2026-08-15 | Duke William E. | Chief Financial Officer | Exercise or conversion | 102K | price not stated in the filing | not stated | 210K |
| 2026-08-15 | Green Julie | Chief Human Resources Officer | Exercise or conversion | 102K | price not stated in the filing | not stated | 210K |
| 2026-08-15 | Lee Timothy Edward | Chief Commercial Officer | Exercise or conversion | 102K | price not stated in the filing | not stated | 220K |
| 2026-02-18 | Andersen Jill | Chief Legal Officer, Secretary | Sell | 35K | $1.58 | $55K | 182K |
| 2026-02-18 | Lee Timothy Edward | Chief Commercial Officer | Sell | 21K | $1.58 | $33K | 118K |
| 2026-02-18 | Duke William E. | Chief Financial Officer | Sell | 21K | $1.58 | $33K | 108K |
| 2026-02-18 | Green Julie | Chief Human Resources Officer | Sell | 21K | $1.58 | $33K | 108K |
| 2026-02-18 | Allen Robert D. III | Chief Scientific Officer | Sell | 19K | $1.58 | $31K | 114K |
| 2026-02-17 | Andersen Jill | Chief Legal Officer, Secretary | Sell | 33K | $1.54 | $50K | 217K |
| 2026-02-17 | Lee Timothy Edward | Chief Commercial Officer | Sell | 20K | $1.54 | $30K | 139K |
| 2026-02-17 | Duke William E. | Chief Financial Officer | Sell | 20K | $1.54 | $30K | 129K |
| 2026-02-17 | Green Julie | Chief Human Resources Officer | Sell | 20K | $1.54 | $30K | 129K |
| 2026-02-17 | Allen Robert D. III | Chief Scientific Officer | Sell | 18K | $1.54 | $28K | 134K |
| 2026-02-15 | Andersen Jill | Chief Legal Officer, Secretary | Exercise or conversion | 165K | price not stated in the filing | not stated | 249K |
| 2026-02-15 | Lee Timothy Edward | Chief Commercial Officer | Exercise or conversion | 99K | price not stated in the filing | not stated | 158K |
| 2026-02-15 | Duke William E. | Chief Financial Officer | Exercise or conversion | 99K | price not stated in the filing | not stated | 148K |
| 2026-02-15 | Green Julie | Chief Human Resources Officer | Exercise or conversion | 99K | price not stated in the filing | not stated | 148K |
| 2026-02-15 | Allen Robert D. III | Chief Scientific Officer | Exercise or conversion | 99K | price not stated in the filing | not stated | 152K |
| 2025-11-19 | MCLAUGHLIN KEVIN F | Director | Buy | 50K | $2.50 | $125K | 50K |
| 2025-08-19 | Allen Robert D. III | Chief Scientific Officer | Sell | 27K | $0.57 | $16K | 53K |
| 2025-08-19 | Andersen Jill | Chief Legal Officer, Secretary | Sell | 49K | $0.57 | $28K | 84K |
| 2025-08-19 | Green Julie | Chief Human Resources Officer | Sell | 30K | $0.57 | $17K | 49K |
| 2025-08-19 | Duke William E. | Chief Financial Officer | Sell | 30K | $0.57 | $17K | 49K |
| 2025-08-19 | Lee Timothy Edward | Chief Commercial Officer | Sell | 30K | $0.57 | $17K | 59K |
| 2025-08-18 | Allen Robert D. III | Chief Scientific Officer | Sell | 19K | $0.65 | $12K | 80K |
| 2025-08-18 | Andersen Jill | Chief Legal Officer, Secretary | Sell | 33K | $0.65 | $22K | 134K |
| 2025-08-18 | Green Julie | Chief Human Resources Officer | Sell | 20K | $0.65 | $13K | 79K |
| 2025-08-18 | Duke William E. | Chief Financial Officer | Sell | 20K | $0.65 | $13K | 79K |
| 2025-08-18 | Lee Timothy Edward | Chief Commercial Officer | Sell | 20K | $0.65 | $13K | 89K |
| 2025-08-15 | Allen Robert D. III | Chief Scientific Officer | Exercise or conversion | 99K | price not stated in the filing | not stated | 99K |
| 2025-08-15 | Andersen Jill | Chief Legal Officer, Secretary | Exercise or conversion | 165K | price not stated in the filing | not stated | 167K |
| 2025-08-15 | Green Julie | Chief Human Resources Officer | Exercise or conversion | 99K | price not stated in the filing | not stated | 99K |
| 2025-08-15 | Duke William E. | Chief Financial Officer | Exercise or conversion | 99K | price not stated in the filing | not stated | 99K |
| 2025-08-15 | Lee Timothy Edward | Chief Commercial Officer | Exercise or conversion | 99K | price not stated in the filing | not stated | 109K |
| 2024-12-31 | MCGUIRE TERRANCE | Director | Sell | 103K | $0.45 | $47K | 3.1M |
| 2024-12-30 | MCGUIRE TERRANCE | Director | Sell | 87K | $0.48 | $42K | 3.2M |
| 2024-12-27 | MCGUIRE TERRANCE | Director | Sell | 84K | $0.52 | $44K | 3.3M |
| 2024-12-26 | MCGUIRE TERRANCE | Director | Sell | 84K | $0.54 | $45K | 3.3M |
| 2024-12-24 | MCGUIRE TERRANCE | Director | Sell | 68K | $0.51 | $35K | 3.4M |
| 2024-12-23 | MCGUIRE TERRANCE | Director | Sell | 76K | $0.45 | $34K | 3.5M |
| 2024-12-20 | MCGUIRE TERRANCE | Director | Sell | 120K | $0.42 | $50K | 3.6M |
| 2024-12-19 | MCGUIRE TERRANCE | Director | Sell | 152K | $0.43 | $65K | 3.7M |
| 2024-12-18 | MCGUIRE TERRANCE | Director | Sell | 75K | $0.47 | $35K | 3.8M |
| 2024-12-17 | MCGUIRE TERRANCE | Director | Sell | 97K | $0.48 | $47K | 3.9M |
| 2024-12-16 | MCGUIRE TERRANCE | Director | Sell | 65K | $0.47 | $31K | 4.0M |
| 2024-12-12 | MCGUIRE TERRANCE | Director | Sell | 125K | $0.58 | $73K | 4.1M |
| 2024-12-11 | MCGUIRE TERRANCE | Director | Sell | 160K | $0.59 | $95K | 4.2M |
| 2024-12-10 | MCGUIRE TERRANCE | Director | Sell | 175K | $0.59 | $103K | 4.4M |
| 2024-12-09 | MCGUIRE TERRANCE | Director | Sell | 150K | $0.61 | $92K | 4.5M |
| 2024-05-29 | MCGUIRE TERRANCE | Director | Sell | 112K | $1.66 | $187K | 4.7M |
| 2024-01-19 | Adimab, LLC | TenPercentOwner | Sell | 5.0M | $3.95 | $19.8M | 21.7M |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON12 Form 144 notices on file for IVVD worth $4.8M at the prices reported; 5 in the last 90 days worth $164K. Latest: Lee Timothy Edward filed on 2026-08-17 to sell 40,800 shares ($29K) from 2026-08-17.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-08-17 | Lee Timothy EdwardOfficer | 41K | $29K | 0.014% | 2026-08-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-17 | Green JulieOfficer | 41K | $29K | 0.014% | 2026-08-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-17 | Duke William E.Officer | 41K | $29K | 0.014% | 2026-08-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-17 | Andersen JillOfficer | 68K | $49K | 0.023% | 2026-08-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-17 | Allen Robert D. IIIOfficer | 38K | $27K | 0.013% | 2026-08-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-17 | Lee Timothy EdwardOfficer | 40K | $62K | 0.014% | 2026-02-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-17 | Green JulieOfficer | 40K | $62K | 0.014% | 2026-02-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-17 | Duke William E.Officer | 40K | $62K | 0.014% | 2026-02-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-17 | Andersen JillOfficer | 66K | $103K | 0.023% | 2026-02-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-17 | Allen Robert D. IIIOfficer | 37K | $57K | 0.013% | 2026-02-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-23 | ADIMAB, LLC10% Stockholder | 192K | $577K | 0.082% | 2025-12-23 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-17 | ADIMAB, LLC10% Stockholder | 1.2M | $3.7M | 0.529% | 2025-11-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first, 50 of 55 shown. JSON20 holders report 5% or more of IVVD in their latest filing, 1 on Schedule 13D (active intent). The largest reported stake is JANUS HENDERSON GROUP PLC at 12.1% of the class (25,383,077 shares), filed 2025-11-14 for an event on 2025-09-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-14 | 13G/Ano. 1 | Perceptive Life Sciences Master Fund, Ltd.corporation | 18.5M | 6.3% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 1 | Perceptive Advisors LLCinvestment adviser | 18.5M | 6.3% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 1 | Joseph Edelmanindividual | 18.5M | 6.3% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 2 | LAMPERT MARK Nindividual | 29.6M | 10.0% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 2 | BVF INC/ILcorporation | 29.6M | 10.0% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 2 | BVF PARTNERS L P/ILinvestment adviser, partnership | 29.6M | 10.0% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 2 | BVF GP HOLDINGS LLCother entity | 27.2M | 9.2% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 2 | BVF I GP LLCother entity | 16.0M | 5.4% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 2 | BIOTECHNOLOGY VALUE FUND L Ppartnership | 16.0M | 5.4% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 2 | BVF II GP LLCother entity | 11.2M | 3.8% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 2 | BIOTECHNOLOGY VALUE FUND II LPpartnership | 11.2M | 3.8% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 2 | Biotechnology Value Trading Fund OS LPpartnership | 1.9M | 0.6% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 2 | BVF Partners OS Ltd.corporation | 1.9M | 0.6% | 2026-06-30 |
| 2026-07-28 | 13G | BlackRock, Inc.parent holding company | 16.1M | 5.5% | 2026-06-30 |
| 2026-05-15 | 13G/Ano. 2 | RA Capital Healthcare Fund, L.P.partnership | 21.3M | 7.0% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 2 | Rajeev Shahparent holding company, individual | 21.3M | 7.0% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 2 | Peter Kolchinskyparent holding company, individual | 21.3M | 7.0% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 2 | RA Capital Management, L.P.investment adviser, partnership | 21.3M | 7.0% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 3 | Steven A. Cohenindividual | 44K | 0.0% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 3 | Point72 Capital Advisors, Inc.corporation | 44K | 0.0% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 3 | Point72 Asset Management, L.P.partnership | 44K | 0.0% | 2026-03-31 |
| 2026-02-13 | 13G/Ano. 3 | Maverick Capital Management, LLCparent holding company | 19.0M | 6.7% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 3 | Maverick Capital, Ltd.investment adviser | 19.0M | 6.7% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 3 | Lee S. Ainslie IIIindividual | 19.0M | 6.7% | 2025-12-31 |
| 2026-02-12 | 13G/Ano. 1 | Guy Levyindividual | 7.7M | 2.8% | 2025-12-31 |
| 2026-02-12 | 13G/Ano. 1 | Soleus GP, LLCother entity | 7.7M | 2.8% | 2025-12-31 |
| 2026-02-12 | 13G/Ano. 1 | Soleus Capital Management, L.P.partnership | 7.7M | 2.8% | 2025-12-31 |
| 2026-02-12 | 13G/Ano. 1 | Soleus Capital Group, LLCother entity | 6.0M | 2.2% | 2025-12-31 |
| 2026-02-12 | 13G/Ano. 1 | Soleus Capital, LLCother entity | 6.0M | 2.2% | 2025-12-31 |
| 2026-02-12 | 13G/Ano. 1 | Soleus Capital Master Fund, L.P.non-US institution | 6.0M | 2.2% | 2025-12-31 |
| 2026-02-12 | 13G/Ano. 1 | Soleus PE GP III, LLCother entity | 1.7M | 0.6% | 2025-12-31 |
| 2026-02-12 | 13G/Ano. 1 | Soleus Private Equity GP III, LLCother entity | 1.7M | 0.6% | 2025-12-31 |
| 2026-02-12 | 13G/Ano. 1 | Soleus Private Equity Fund III, L.P.partnership | 1.7M | 0.6% | 2025-12-31 |
| 2025-12-29 | 13D/Ano. 5 | Adimab, LLCother entity | 20.3M | 7.3% | 2025-12-23 |
| 2025-11-14 | 13G/Ano. 1 | JANUS HENDERSON GROUP PLCinvestment adviser, parent holding company | 25.4M | 12.1% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 1 | Janus Henderson Biotech Innovation Master Fund Ltdinvestment company | 21.6M | 10.3% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 3 | Deep Track Biotechnology Master Fund, Ltd.corporation | 0 | 0.0% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 3 | Deep Track Capital, LPinvestment adviser, other entity | 0 | 0.0% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 3 | David Kroinparent holding company, individual | 0 | 0.0% | 2025-09-30 |
| 2025-11-12 | 13D/Ano. 5 | Mithril II UGP LLCother entity | 11.2M | 4.8% | 2025-08-22 |
| 2025-11-12 | 13D/Ano. 5 | Mithril II GP LPpartnership | 11.2M | 4.8% | 2025-08-22 |
| 2025-11-12 | 13D/Ano. 5 | Mithril II LPpartnership | 11.2M | 4.8% | 2025-08-22 |
| 2025-11-12 | 13D/Ano. 5 | Peter Thielindividual | 11.2M | 4.8% | 2025-08-22 |
| 2025-11-12 | 13D/Ano. 5 | Ajay Royanindividual | 11.2M | 4.8% | 2025-08-22 |
| 2025-11-07 | 13D/Ano. 5 | Terrance McGuireindividual | 7.0M | 3.0% | 2025-08-22 |
| 2025-11-07 | 13D/Ano. 5 | Jonathan Flintindividual | 3.2M | 1.4% | 2025-08-22 |
| 2025-11-07 | 13D/Ano. 5 | Polaris Venture Management Co. V, L.L.C. | 3.2M | 1.4% | 2025-08-22 |
| 2025-11-07 | 13D/Ano. 5 | Polaris Venture Partners V, L.P.partnership | 3.1M | 1.3% | 2025-08-22 |
| 2025-11-07 | 13D/Ano. 5 | Polaris Partners GP IX, L.L.C.other entity | 3.1M | 1.3% | 2025-08-22 |
| 2025-11-07 | 13D/Ano. 5 | Polaris Partners IX, L.P.partnership | 3.1M | 1.3% | 2025-08-22 |
13F holders
Tracked managers holding IVVD at their latest 13F. JSON5 of the 30 tracked managers held IVVD at their latest 13F, $13.7M in total at quarter-end prices. Point72 Asset Management is the largest at $6.6M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 4 added shares and 1 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Point72 Asset Management | 2026-06-30 | 7.5M | $6.6M | 0.01% | +7.5M |
| Citadel Advisors | 2026-06-30 | 3.6M | $3.1M | 0.00% | +2.0M |
| Two Sigma Investments | 2026-06-30 | 2.3M | $2.0M | 0.00% | +364K |
| Millennium Management | 2026-06-30 | 1.2M | $1.1M | 0.00% | -2.3M |
| Renaissance Technologies | 2026-06-30 | 995K | $868K | 0.00% | +149K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
Invivyd in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Invivyd (IVVD), SEC CIK 1832038, listed on Nasdaq, classified by the SEC as biological products, (no diagnostic substances). The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-03.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-13.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-08-17.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-14.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-13.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-08-18.JSON and CSV
- Company record
- EDGAR filing index for CIK 1832038Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as biological products, (no diagnostic substances)
Other company pages
Datasets
Frequently Asked Questions
How much of IVVD is sold short?
37,046,611 shares were held short at the 2026-10-15 settlement, 6.9 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is IVVD's daily short volume?
On 2026-11-03, 1,538,988 of the 2,466,449 IVVD shares reported to FINRA were sold short, 62.4% of the day's reported volume. Short volume is a flow for one day, not a position.
Does IVVD have fails to deliver?
The SEC's latest file shows 1,000 IVVD shares failed to deliver at settlement 2026-10-13. Fails are reported per settlement date and published twice a month with a lag.
Are IVVD insiders buying or selling?
Insiders at IVVD reported 10 open-market sells worth $177K in the last 90 days and no open-market buys. Latest filing: Allen Robert D. III (Chief Scientific Officer) on 2026-08-18.
Have IVVD insiders filed to sell?
12 Form 144 notices on file for IVVD worth $4.8M at the prices reported; 5 in the last 90 days worth $164K. Latest: Lee Timothy Edward filed on 2026-08-17 to sell 40,800 shares ($29K) from 2026-08-17.
Who owns 5% or more of IVVD?
20 holders report 5% or more of IVVD in their latest filing, 1 on Schedule 13D (active intent). The largest reported stake is JANUS HENDERSON GROUP PLC at 12.1% of the class (25,383,077 shares), filed 2025-11-14 for an event on 2025-09-30.
Which tracked 13F managers own IVVD?
5 of the 30 tracked 13F managers held IVVD shares at their latest filing, $13.7M in all. The largest: Steve Cohen's Point72 Asset Management (7.5M shares, $6.6M), Ken Griffin's Citadel Advisors (3.6M shares, $3.1M), Two Sigma Investments (2.3M shares, $2.0M), Izzy Englander's Millennium Management (1.2M shares, $1.1M), Renaissance Technologies (995K shares, $868K).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.